Low serum Se is independently associated with anemia in elderly population, dialysis patients, 
Introduction
Anemia is a significant human health problem caused by multiple etiologies. Intrinsic defects in erythropoietic progenitors can impair hemoglobin production and the generation of new erythrocytes as observed in sickle cell anemia and thalassemia. In addition, many anemias present as a secondary pathology as observed in the anemia of inflammation and anemias caused by nutritional deficiencies (1) (2) (3) (4) (5) . Although one of the leading causes of anemia in the United States and worldwide is the nutritional deficiency of iron, deficiencies in other trace elements are associated with anemia have been characterized (6) . Low serum Se was also independently associated with anemia among older men and women in the USA and elsewhere (7) (8) (9) . Dialysis patients showed significantly lower plasma Se levels that correlated with decreased half-lives of erythrocytes and thrombocytes compared to healthy controls (10) . In sickle cell anemia patients, Se deficiency was associated with decreased expression of the highly Se-responsive selenoprotein glutathione peroxidase-1 (GPX1) in addition to a weakened antioxidant potential (11) . A causal association between hypothyroidism and anemia (12) and subclinical hypothyroidism, due to Se deficiency (and decreased selenoprotein deiodinases), was associated with lower hemoglobin levels (13) . Altogether, these studies suggest a key role for Se in erythropoiesis during anemia. The standard treatments for anemia include whole blood transfusion and administration of recombinant human erythropoietin (rhEpo). However, transfusion therapy poses problems in the treatment of chronic anemia with increased risk of allo-immunization and the potential to induce inflammation or infection. rhEpo is not effective in all types of anemia and can compromise chemotherapy (5, (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Therefore, the development of new treatments for anemia is a significant unmet need in the field.
One approach to identifying new therapies is to better understand the physiological response to anemic stress. Steady state erythropoiesis is primarily homeostatic and produces new erythrocytes at a constant rate. However, when the bone marrow cannot generate sufficient erythrocytes, stress erythropoiesis predominates (24) . Stress erythropoiesis is best understood in mice where it occurs extra-medullary in the adult spleen and liver (24) (25) (26) (27) (28) . Unlike steady state erythropoiesis, stress erythropoiesis utilizes a set of progenitors and signals that are distinct from the ones used in bone marrow erythropoiesis (29, 30 Bmp4 expressed in the spleen microenvironment specify the cells as stress-erythroid progenitors (SEPs), a set of erythroid restricted cells (29) . During the second stage, anemic stress induces the rapid proliferation of these cells in the spleen, but they maintain their stem cell markers and retain their undifferentiated state (27, 31, 32 ). An influx of erythropoietin (Epo) marks the third stage which induces a transition from proliferating stem cell like progenitor to committed erythroid progenitor. At this point cells acquire the ability to differentiate (31, 32) . During the final stage, the stress erythroid progenitors synchronously differentiate to generate a wave of new erythrocytes that maintain erythroid homeostasis until the bone marrow can resume production.
It is expected that a better understanding of the mechanisms that regulate stress erythropoiesis would identify new targets for therapeutic intervention to treat anemia without relying on transfusion or injection of rhEpo.
Selenoproteins function as redox gatekeepers in cells via the active site Sec residue. In addition to the hierarchical expression pattern, selenoproteins possess varying degrees of peroxidase activity (33) . Some selenoproteins also contain a thioredoxin-like fold with a conserved CxxU (C:
Cys; U: Sec) motif that is critical for its function as a disulfide reductase in concert with other redox couples, which is preceded by an interaction with cellular protein substrates.
Erythropoiesis and erythrocytes are particularly prone to oxidative stress due to the presence of iron, heme and O 2 . Mutation of Trsp, which encodes the tRNA [Sec] , abolishes selenoprotein production and is embryonic lethal (34) . However, conditional deletion in the hematopoietic system leads to increased oxidative stress and induction of the Nrf2-dependent antioxidant pathway. Double mutants in Trsp and Nrf2 exhibit an exacerbated anemia characterized by increased levels of H 2 O 2 in erythroblasts demonstrating that increased oxidative stress profoundly affects erythroid development (35) . Previous work from our laboratory showed that dietary Se deficiency leads to increased hemoglobin oxidation and formation of Heinz bodies (36) . Se-deficient mice exhibit a mild anemia. Recently we demonstrated that Se deficiency or lack of selenoproteins due to conditional deletion of Trsp in hematopoietic cells severely compromised stress erythropoiesis at several levels (37) . Deficits in selenoproteins blocked the expansion and development of stress burst forming unit-erythroid cells (BFU-E) and caused defects in terminal differentiation. Analysis of selenoprotein expression showed that selenoprotein W (SelenoW) was highly expressed in developing SEPs. CRISPR-Cas9 knockout of SelenoW blocked the proliferation of immature stress progenitors in murine and human stress erythropoiesis cultures demonstrating a central role for SelenoW in stress erythropoiesis (37) .
Selenoprotein N (SelenoN) is another Sec containing protein localized in the endoplasmic reticulum (ER) lumen, ubiquitously expressed in all tissues. However, loss-of-function of the SELENON gene leads to a group of neuromuscular disorders referred to as SelenoN(SEPN1)-related myopathies characterized by trunk muscle atrophy, scoliosis, and respiratory defects (38) .
This muscle specific phenotype in human and studies on SelenoN -/-mouse suggested that, despite its widespread expression, this selenoprotein is particularly important in molecular processes relevant to muscle development and maintenance (38) . Interestingly, decreased SelenoW expression was also linked to the development of a muscle phenotype in cattle, the white muscle disease. SelenoN -/-mouse suggested that this selenoprotein essential for muscle regeneration and satellite cell maintenance in mice and humans (39) . While the function of SelenoN has been elusive, recent breakthroughs have indicated that SelenoN protects the ER from hydroperoxides generated by the endoplasmic reticulum oxidoreductin-1 (ERO1), an ER thiol oxidase, to restore calcium homeostasis (40) . SelenoN was reported to interact with the sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) pump via its thioredoxin motif indicating a redox-dependent enhancement of its function in Ca 2+ homoestasis (40) . Ca 2+ signaling regulates the response to ER stress through the activation of Perk kinase (Eif2aK3), which plays a key role in regulating muscle satellite cell quiescence and self-renewal (41, 42 
Materials and Methods
C57BL/6 mice of both sexes were maintained on unrestricted access to lab chow and water.
Approximately eight to 12-week old mice were used to isolate bone marrow. For the PHZ challenge experiment, eight to ten-months old SelenoN -/-male mice on a C57BL/6 background were used and compared to SelenoN +/-littermates. All procedures were performed under guidelines from the Animal Use and Care Committee at Pennsylvania State University.
Phenylhydrazine treatment-Mice were injected intraperitoneally with PHZ at a dose of 100 mg/kg body weight as previously described (37) . Peripheral blood was collected for hematocrit measurement, using heparinized 75µL microhaematocrit capillary tubes. Capillary tubes were centrifuged at 500g for 10 min and both total blood volume and blood cell pellet were measured.
Percentage hematocrit was defined as the ratio of blood cells over total blood volume.
Ex-vivo culture of SEPs-Bone marrow from WT C57BL/6 mice were cultured in the two-phase culture system as described recently (37) . Briefly, bone marrow cells were cultured in the stress erythroid expansion media (SEEM), which comprised of Iscove's Modified Dulbecco's Media
glutamine, Insulin (10μg/mL), Transferrin (200μg/mL), Scf (50ng/mL), Bmp4 (15ng/mL), Gdf15 (30ng/mL), and Shh (25ng/mL), for seven days to enrich for SEPs. Following expansion, the above cells were shifted to stress erythroid differentiation media (SEDM), which is SEEM supplemented with recombinant erythropoietin (Epo; 3U/mL), and the cultures grown in hypoxia conditions (1% O 2 , 5% CO 2 , 37 o C) for three days. Cells were isolated from the SEDM media on day1 and day 3, referred to as D1 and D3, respectively, and used in qPCR assays.
Quantitative polymerase chain reaction (qPCR) and gene expression analysis-RNA isolation
from cells or tissues was performed using TRIzol reagent (Life Technologies) according to the manufacturer's instructions. cDNA was synthesized by using High Capacity cDNA Reverse
Transcriptase kit (Applied Biosystems). qPCR reactions were performed with SYBR™ green master mix (Quanta Biosciences). Primer sequences are as follows:
Results and Discussion
SEPs develop from short-term reconstituting hematopoietic stem cells (CD34 + Kit + Sca1 + Lin -; STHSCs) that migrate to the spleen and adopt a stress erythroid fate (28, 29) . The proliferation and transition to differentiation must be coordinated to ensure that sufficient new erythrocytes are produced. Our recently published data show that dietary Se deficiency or mutations that block the production of selenoproteins severely compromise stress erythropoiesis (37) . We observed defects at multiple levels. Immature SEPs failed to proliferate in-vivo and in-vitro along with defective development and differentiation of BFU-Es.
The transition from proliferating SEPs to committed erythroid progenitors capable of forming BFU-E colonies is regulated by Epo signaling. We have developed an in vitro culture system that recapitulates the events in vivo and generates functional SEPs that are transplantable (32) .
Mutation of ATF4 leads to defects in the development of stress BFU-E, which suggests that ER stress may play a role in regulating stress erythropoiesis (43) . Translation of ATF4 is induced by Ca 2+ dependent activation of Perk kinase (44, 45) . We examined the change in expression of ERresident selenoproteins that play a key role in Ca 2+ homeostasis in SEPs on days 1 and 3 after
Epo was added to the media to induce the transition to differentiation. Analysis of selenoprotein expression in SEPs showed that SelenoN was significantly upregulated when cultures were switched from expansion media (SEEM) to Epo containing differentiation media (SEDM). In addition to SelenoN, only Txnrd2 and SelenoO showed statistically significant changes in expression at the transcript level (Fig 1) .
Txnrd2 is a pyridine nucleotide-disulfide oxidoreductase and a part of the thioredoxin (Trx):
thioredoxin reductase redox couple. Unlike Txnrd1 that is cytoplasmic, Txnrd2 is a mitochondrial enzyme that scavenges reactive oxygen species during ER stress and is also known to suppress the therapeutic efficacy of proteasome inhibitors such as bortezomib (Velcade) (46 Mouse bone marrow was cultured in SEEM for seven days followed by SEDM for one day (D1) or three days (D3). Expression of selenoproteins was determined by quantitative PCR. All samples were normalized to the expression of Gapdh. The data was compared to cells cultured for seven days in SEEM media. Data shown is n = 3 per time point; *, **, ***: p<0.05; p<0.01; p<0.005, respectively.
Figure 2: Analysis of hematocrit during recovery in SelenoN
+/-and SelenoN -/-mice upon treatment with 100 % PHZ. Age and sex-matched SelenoN +/-and SelenoN -/-mice were administered phenylhydrazine (PHZ) at 100 mg/kg body weight and the hematocrit were followed during 10 days post PHZ administration. Data shown (mean hematocrit ± SEM) is n = 4-5 per genotype; *, p<0.05
